Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
The Director of Development (DoD), Northeast, will be an integral member of the regional Development team who will research, identify, cultivate, solicit, and steward donors in one of the University’s
-
. The individual in this role will focus on developmental workstreams that will prepare Georgetown for the launch and growth of undergraduate and graduate offerings in Miami, including early graduate programming
-
The CRM and Integration Developer, University Information Services (UIS) - Georgetown University designs, implements, and maintains systems that control user access to organizational resources, ensuring
-
The Director of Development, School of Foreign Service (DOD, SFS) is a vital member of the school’s frontline fundraising team and will play a critical role in building connectivity, engagement
-
empirical approaches to legal interpretation (see https://solid-symposium.github.io/2025/ for examples of interdisciplinary research in this space). We seek candidates with a Ph.D. in Linguistics, Computer
-
developments within the field of behavioral threat assessment and management. Duties include but are not limited to: ● Support case investigations, assessments, and management planning through notetaking
-
The Director of Salesforce, University Information Services (UIS) - Georgetown University leverages native Salesforce functionality, custom Apex development, and integrations with external systems
-
391.11 (4) – Medical Card/Certificate and 390.5 (1) – Commercial Motor Vehicles (10K+) Definitions ( http://www.fmcsa.dot.gov ). Work Mode Designation This position has been designated as On-Campus. Please
-
Taylor and to Dr. Randi Williams. To learn more, please see our website https://lunghealth.georgetown.edu/ . Requirements and Qualifications Bachelor's or Master's degree in pre-med, psychology, public
-
This position will serve to support the research of the Glazer Lab to carry out drug development studies characterizing the action of an LXR agonist on inhibiting tumor progression and normalizing